Litcius/Paper detail

Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomised, controlled, open-label, phase 3 trial

Ken Kato, Ryunosuke Machida, Yoshinori Ito, Hiroyuki Daiko, Soji Ozawa, Takashi Ogata, Hiroki Hara, Takashi Kojima, Tetsuya Abe, Takeo Bamba, Masaya Watanabe, Hirofumi Kawakubo, Yuichi Shibuya, Yasuhiro Tsubosa, Naoki Takegawa, Takeshi Kajiwara, Hideo Baba, Masaki Ueno, Hiroya Takeuchi, Kenichi Nakamura, Yuko Kitagawa, Yuko Kitagawa, Yoshito Komatsu, Yuji Akiyama, Masanobu Takahashi, Kenji Amagai, Naoyuki Matsushita, Hiroki Hara, Hiroshi Sato, Takashi Kojima, Keiko Minashi, Hisahiro Matsubara, Yuji Kikuchi, Ken Kato, Ken Kato, Kosuke Narumiya, Yuko Kitagawa, Yutaro Kubota, Masayuki Watanabe, Masaki Ueno, Soji Ozawa, Takashi Ogata, Takeo Bamba, Hiroshi Ichikawa, Masaya Watanabe, Yasuhiro Tsubosa, Hiroya Takeuchi, Tetsuya Abe, Masahiko Koike, Shigeru Tsunoda, Yuichiro Doki, Hiroshi Miyata, Motohiro Hirano, Hiroko Ikeda, Masahiro Goto, Hironobu Minami, Toru Masuzawa, Masahiro Tsuda, Morihito Okada, Hidenori Mukai, Takeshi Kajiwara, Yuichi Shibuya, Masaru Morita, Eishi Baba, Hideo Baba, Masafumi Inomata, Ken Sasaki

2024The Lancet233 citationsDOI

Topics & Concepts

ChemotherapyMedicineOncologyRadiation therapyOpen labelInternal medicineRandomized controlled trialEsophageal Cancer Research and TreatmentColorectal and Anal CarcinomasPancreatic and Hepatic Oncology Research